Table 1 Baseline characteristics in the RCT.
Characteristics | SSRIs (n = 40) | SSRIs + SIA (n = 40) | SSRIs + AIA (n = 40) | All participates (n = 120) |
|---|---|---|---|---|
Age (years), mean (SD) | 35.2 (13.0) | 31.2 (10.8) | 30.0 (10.8) | 32.1 (11.7) |
Sex, no. (%) | ||||
Female | 31 (77.5) | 32 (80.0) | 32 (80.0) | 95 (79.2) |
Male | 9 (22.5) | 8 (20.0) | 8 (20.0) | 25 (20.8) |
BMI (kg/m3), mean (SD) | 21.1 (2.4) | 21.8 (3.4) | 21.0 (2.7) | 21.3 (2.9) |
Education, no. (%) | ||||
Primary and secondary | 19 (47.5) | 16 (40.0) | 19 (47.5) | 54 (45.0) |
Tertiary and above | 21 (52.5) | 24 (60.0) | 21 (52.5) | 66 (55.0) |
Course of disease (months), mean (SD) | 28.7 (43.5) | 22.3 (34.5) | 24.3 (26.5) | 25.1 (35.3) |
Use of SSRIs, no. (%) | ||||
Fluvoxamine | 15 (37.5) | 14 (35.0) | 16 (40.0) | 45 (37.5) |
Fluoxetine | 7 (17.5) | 10 (25.0) | 7 (17.5) | 24 (20.0) |
Sertraline | 8 (20.0) | 9 (22.5) | 10 (25.0) | 27 (22.5) |
Escitalopram | 9 (22.5) | 7 (17.5) | 6 (15.0) | 22 (18.3) |
Paroxetine | 1 (2.5) | 0 (0.0) | 1 (2.5) | 2 (1.7) |
Acupucture expectation score, mean (SD) | 2.8 (1.0) | 3.1 (0.9) | 3.2 (0.8) | 3.0 (0.9) |
HAMD-17 score, mean (SD) | 21.1 (3.6) | 20.1 (3.7) | 21.5 (4.4) | 20.9 (3.9) |
SDS score, mean (SD) | 68.3 (7.8) | 66.8 (8.0) | 72.7 (9.0) | 69.2 (8.6) |
PSQI score, mean (SD) | 15.4 (4.4) | 15.3 (3.9) | 14.7 (3.5) | 15.1 (4.0) |
